United States Anesthesia Drugs Market, Size, Forecast Report 2022-2027: Industry Trends, Share, Growth, Impact of COVID-19, Opportunities, Company Analysis - ResearchAndMarkets.com
Retrieved on:
Wednesday, February 9, 2022
Health, Pharmaceutical, Policy, Blue Shield, Hypokinesia, Anesthetic, Isoflurane, Medicare, Medicine, Sevoflurane, Unconsciousness, Time, US, Benzodiazepine, Incidence, Methohexital, Fentanyl, COVID-19, Hospital, Bupivacaine, Brain, Etomidate, Analgesic, Anthem (company), Desflurane, Endo International, Drug, CAGR, Baxter International, Pharmaceutical industry, Propofol, Anesthesia, Ketamine, AbbVie, Growth, Pentobarbital
The "United States Anesthesia Drugs Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
Key Points:
- The "United States Anesthesia Drugs Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
- United States Anesthesia Drugs Market will reach US$ 6.2 Billion by 2027 from $4.9 Billion in 2021, growing at a CAGR of 4%.
- Covid-19 Impact on the United States Anesthesia Drugs Industry:
The COVID-19 pandemic has significantly affected the United States anesthesia drugs market. - On the basis of type, United States anesthesia drugs market includes General Inhalation Anesthesia Drugs market, General Intravenous Anesthesia Drugs Market and Local Anesthesia Drugs Market.